Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 2, 2022 | HCA | Buy | 4,128 | $209.73 | $866K |
| May 2, 2022 | HCA | Buy | 37,623 | $210.60 | $7.9M |
| May 2, 2022 | HCA | Buy | 3,606 | $212.60 | $767K |
| May 2, 2022 | HCA | Buy | 7,683 | $213.47 | $1.6M |
| May 2, 2022 | HCA | Buy | 7,577 | $215.29 | $1.6M |
| May 2, 2022 | HCA | Buy | 12,170 | $214.48 | $2.6M |
| May 2, 2022 | HCA | Buy | 16,313 | $211.22 | $3.4M |
| Feb 20, 2018 | HCA | Buy | 28,650 | $101.07 | $2.9M |
| May 5, 2017 | HCA | Buy | 71,850 | $83.47 | $6.0M |
| May 5, 2017 | HCA | Buy | 1,755 | $84.14 | $148K |
| May 4, 2017 | HCA | Buy | 21,989 | $82.40 | $1.8M |
| May 4, 2017 | HCA | Buy | 73,190 | $82.84 | $6.1M |
| May 4, 2017 | HCA | Buy | 25,421 | $83.58 | $2.1M |
| May 3, 2017 | HCA | Buy | 167,000 | $82.97 | $13.9M |
SEC reporting-owner ID (CIK) 900596 · all filings on EDGAR